Similar articles

• Response to therapy in carnitine/acylcarnitine translocase (CACT) deficiency due to a novel missense mutation.

  Iacobazzi V, Pasquali M, Singh R, Matern D, Rinaldo P, Amat di San Filippo C, Palmieri F, Longo N. Iacobazzi V, et al. Am J Med Genet A. 2004 Apr 15;126A(2):150-5. doi: 10.1002/ajmg.a.20573. Am J Med Genet A. 2004. PMID: 15057979
• Molecular and functional analysis of SLC25A20 mutations causing carnitine-acylcarnitine translocase deficiency.

  Iacobazzi V, Invernizzi F, Baratta S, Pons R, Chung W, Garavaglia B, Dionisi-Vici C, Ribes A, Parini R, Huertas MD, Roldan S, Lauria G, Palmieri F, Taroni F. Iacobazzi V, et al. Hum Mutat. 2004 Oct;24(4):312-20. doi: 10.1002/humu.20085. Hum Mutat. 2004. PMID: 15365988
• Carnitine-acylcarnitine translocase deficiency: identification of a novel molecular defect in a Bedouin patient.

  Galron D, Birk OS, Kazanovitz A, Moses SW, Hershkovitz E. Galron D, et al. J Inherit Metab Dis. 2004;27(2):267-73. doi: 10.1023/B:BOLI.0000028780.01670.61. J Inherit Metab Dis. 2004. PMID: 15159657 Review.
• Diagnosis of carnitine acylcarnitine translocase deficiency by complementation analysis.

  Brivet M, Slama A, Ogier H, Boutron A, Demaugre F, Saudubray JM, Lemonnier A. Brivet M, et al. J Inherit Metab Dis. 1994;17(3):271-4. doi: 10.1007/BF00711805. J Inherit Metab Dis. 1994. PMID: 7807931 No abstract available.
• Carnitine-acylcarnitine translocase deficiency: case report and review of the literature.

  Rubio-Gozalbo ME, Vos P, Forget PP, Van Der Meer SB, Wanders RJ, Waterham HR, Bakker JA. Rubio-Gozalbo ME, et al. Acta Paediatr. 2003 Apr;92(4):501-4. doi: 10.1111/j.1651-2227.2003.tb00586.x. Acta Paediatr. 2003. PMID: 12801121 Review.